Clinical Trials Browser

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT04086485 2026-04-07

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Phase 1/2 Recruiting

56 enrolled

EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT03206060 2026-04-01

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Phase 2 Recruiting

130 enrolled

CNSEndocrineNET

Hypertension, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

NCT06122610 2026-03-19

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Phase 1 Recruiting

10 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT04954820 2026-02-05

ReLUTH

Phase 2 Recruiting

146 enrolled

EndocrineNET

Neuroendocrine Tumors, Disease Progression

NCT05178693 2025-11-24

LANTana

Phase 1 Recruiting

27 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT06878664 2025-09-02

RIALTO

Phase 3 Recruiting

166 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT06395402 2025-07-22

LUMOD-ID

Phase 2 Recruiting

120 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT04917484 2024-12-09

DOBATOC

Phase 2 Recruiting

100 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT04949282 2022-12-23

SEPTRALU

Recruiting

5,000 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pancreatic Diseases, Pancreatic Neoplasms, Stomach Neoplasms, Neuroectodermal Tumors, Neuroendocrine Tumors

Clinical Trials

LUPARPED

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

ReLUTH

LANTana

RIALTO

LUMOD-ID

DOBATOC

SEPTRALU